Concurrent Investment Advisors LLC Reduces Stock Position in The Clorox Company (NYSE:CLX)

Concurrent Investment Advisors LLC reduced its holdings in The Clorox Company (NYSE:CLXFree Report) by 5.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,287 shares of the company’s stock after selling 797 shares during the period. Concurrent Investment Advisors LLC’s holdings in Clorox were worth $2,483,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Insight Folios Inc lifted its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after acquiring an additional 63 shares during the last quarter. HCR Wealth Advisors lifted its holdings in shares of Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after acquiring an additional 68 shares during the last quarter. Empower Advisory Group LLC lifted its holdings in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after acquiring an additional 78 shares during the last quarter. Aviance Capital Partners LLC lifted its holdings in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after acquiring an additional 80 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its holdings in shares of Clorox by 9.9% in the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after acquiring an additional 88 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 2.8 %

Shares of Clorox stock opened at $157.41 on Friday. The firm’s 50 day moving average price is $157.87 and its 200-day moving average price is $159.63. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market cap of $19.39 billion, a P/E ratio of 43.01, a PEG ratio of 2.58 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company posted $2.16 EPS. On average, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CLX. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Finally, Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average target price of $158.21.

Get Our Latest Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.